The short-term health outcome of out-patient rheumatology consultations in relation to rationing: A pilot study

British Journal of Rheumatology

Volumn 37, Issue 5, 1998, Pages 509-513

  Hurst, N P ^a   McRorie, E R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Ambulatory care; Audit; EuroQol; Out patients; Outcome; Rationing; Rheumatoid disease

Indexed keywords

ARTICLE; CONSULTATION; DIAGNOSIS RELATED GROUP; FEMALE; HEALTH CARE ORGANIZATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RHEUMATIC DISEASE;

EID: 0031853181     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.5.509     Document Type: Article

References (18)

1. Cohen G, Forbes J, Garraway M. Interpreting self-reported limiting long term illness. Br Med J 1995;311:722-4.
2. Kirwan JR. Rheumatology out-patient workload increases inexorably. Br J Rheumatol 1997;36:481-6.
3. Kirwan JR, Dieppe P, Snow S. Consultant appointments and their effect on out-patient appointments. Br J Rheumatol 1989;28:453-4.
4. Bamji AN, Dieppe P, Haslock I, Shipley ME. What do rheumatologists do? A pilot audit study. Br J Rheumatol 1990;29:295-8.
5. Hurst NP. Rheumatoid arthritis in Scotland - A review of its impact on public health, the economy and health services. Health Bull 1994;52:198-206.
6. Klein R. Dimensions of rationing: who should do what? Br Med J 1993;307:309-11.
7. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996; 39:713-22.
8. Brazier J, Jones N, Kind P. Testing the validity of the EuroQol and comparing it with the SF36 health survey questionnaire. Qual Life Res 1993;2:169-80.
9. Hurst NP, Kind P, Ruta D et al. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997;36:551-9.
10. Dolan P, Gudex C, Kind P, Williams A. Social tariff for EuroQol: results from a UK general population survey. Discussion Paper 138. York: Centre for Health Economics, York University.
11. Van der Heide A, Jacobs JWG et al. The effectiveness of early treatment with second-line anti-rheumatic drugs: a randomised controlled trial. Ann Intern Med 1996;124:699-707.
12. Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14 year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
13. Weinblatt ME et al. Methotrexate in rheumatoid arthritis: a five year prospective multicenter study. Arthritis Rheum 1994;37:1492-8.
14. Emery P, Salmon M. Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995;54:944-7.
15. Scott DL, Symmons DPM, Coulton BL, Popert AJ. Long term outcome of treating rheumatoid arthritis. Results after 20 years. Lancet 1987;i:1108-11.
16. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughan WK. Severe functional declines, work disability, and increased mortality in 75 rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
17. Pimm TJ, Byron MA, Curson D et al. Quality of life in rheumatoid arthritis - an individualized approach. Br J Rheumatol 1997;36(suppl. 1):148.
18. Maynard A. Rationing health care. Br Med J 1996;313:1499.